Stay updated on Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Site revision updated to v3.5.0, replacing the previous v3.4.3 version.
    Difference
    0.0%
    Check dated 2026-03-18T17:44:51.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed. This indicates a minor platform update with no changes to study page content or visible functionality.
    Difference
    0.0%
    Check dated 2026-03-11T17:04:50.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    A minor site update adds Revision: v3.4.2 and removes the previous maintenance notice (Revision: v3.4.1) related to government funding.
    Difference
    0.3%
    Check dated 2026-02-11T04:55:23.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    A government funding notice and site status message are now displayed, and the revision label updated from v3.4.0 to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-04T05:36:54.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option and updated wording for No FEAR Act data, capitalization of QC criteria labels, and revision notes (v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T04:08:54.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Revision metadata updated: added Revision: v3.3.4 and removed Revision: v3.3.3. No substantive changes to the study content (e.g., eligibility criteria, outcomes, or interventions) are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T02:48:44.000Z thumbnail image

Stay in the know with updates to Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial page.